Home Cart 0 Sign in  

[ CAS No. 90-99-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 90-99-3
Chemical Structure| 90-99-3
Structure of 90-99-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 90-99-3 ]

Related Doc. of [ 90-99-3 ]

Alternatived Products of [ 90-99-3 ]

Product Details of [ 90-99-3 ]

CAS No. :90-99-3 MDL No. :MFCD00000855
Formula : C13H11Cl Boiling Point : -
Linear Structure Formula :- InChI Key :ZDVDCDLBOLSVGM-UHFFFAOYSA-N
M.W : 202.68 Pubchem ID :7035
Synonyms :

Calculated chemistry of [ 90-99-3 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.08
Num. rotatable bonds : 2
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 60.69
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.5
Log Po/w (XLOGP3) : 3.94
Log Po/w (WLOGP) : 3.69
Log Po/w (MLOGP) : 4.41
Log Po/w (SILICOS-IT) : 4.23
Consensus Log Po/w : 3.76

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.08
Solubility : 0.0168 mg/ml ; 0.000083 mol/l
Class : Moderately soluble
Log S (Ali) : -3.64
Solubility : 0.0465 mg/ml ; 0.000229 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.58
Solubility : 0.000528 mg/ml ; 0.00000261 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.94

Safety of [ 90-99-3 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P234-P264-P280-P390-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405 UN#:3265
Hazard Statements:H314-H290 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 90-99-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 90-99-3 ]
  • Downstream synthetic route of [ 90-99-3 ]

[ 90-99-3 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 90-99-3 ]
  • [ 7431-45-0 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 24, p. 3581 - 3585
  • 2
  • [ 142-64-3 ]
  • [ 90-99-3 ]
  • [ 841-77-0 ]
YieldReaction ConditionsOperation in experiment
80% With potassium carbonate In tetrahydrofuranReflux Compound, 2 (250 mg, 1.23 mmol) was taken in THF, and piperazinedihydrochloride (199 mg, 1.25 mmol) and K2CO3 (690mg, 5 mmol) were added. The reaction mixture was refluxed overnight.After complete reaction the solvent was removed under reduced pressure and theprecipitate obtained was washed with water and hexane (5 x 3ml). The crudeproduct was purified by column chromatographyusing gradient of ethylacetate andhexane (20 percent v/v) to obtain off white color compound. Yield 80 percent (250mg). M.p. 91-92C. 1H NMR(300 MHz, CDCl3) δ (ppm): 7.38-7.12 (m, 10 H), 4.21 (s, 1H),2.40 (Br, 8 H).
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 28, p. 3688 - 3693
[2] Medicinal Chemistry Research, 2007, vol. 16, # 4, p. 179 - 187
[3] European Journal of Medicinal Chemistry, 2009, vol. 44, # 3, p. 1223 - 1229
[4] Medicinal Chemistry Research, 2014, vol. 23, # 6, p. 3207 - 3219
  • 3
  • [ 110-85-0 ]
  • [ 90-99-3 ]
  • [ 841-77-0 ]
YieldReaction ConditionsOperation in experiment
215 g at 60 - 100℃; General procedure: NaBH4 (0.6mol) was added to a stirred solution of benzophenones (1.0 mol)in methanol (2 vol) portionwise at room temperature for 45 min. The mixture was stirred for 2–3 h at ambient temperature (completion of reaction was monitoredby TLC), and was diluted with water (750 ml), acidified with acetic acid to pH 4,and extracted with dichloromethane (2x400 ml). The organic layer was washed with water (200 ml) and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure to get pure benzhydrol derivatives as a white to off-white solid in 93–97percent yield. To the benzhydrol derivatives (1.0 mol) in toluene (370 ml) was added concentrated HCl (35percent in H2O, 370 ml) and tetrabutylammonium bromide(0.01 mol) at room temperature under stirring. Stirring was continued at 40–45 °C for 6–7 h. After completion of the reaction as indicated by TLC, the mixture was cooled to room temperature. The organic layer was separated and concentrated under vacuum to obtain crude benzhydryl chloride derivatives as a light brown liquid in 95–97percent yield. To this benzhydryl chloride (0.96 mol) derivatives in toluene (380 ml) was added anhydrous piperazine (5.0 mol) at 60–70 °C for 45–60 min. The resulting mixture was heated under stirring at 90–100 °C for 8–10 h. The mixture was cooled after completion of the reaction. Water (380 ml) was added, and the organic layer was separated. The latter was washed with a 1:1 mixture of concentrated HCl/water(2x350 ml) and neutralized with 20percent NaOH solution (750 ml). The water layer was re-extracted into toluene (2x300 ml), dried over anhydrous sodium sulfate, and concentrated under vacuum to result pure diphenylmethylpiperazine compounds (2a–c) as a white to off-white solid with yields up to 88percent.
Reference: [1] Chemical and Pharmaceutical Bulletin, 1999, vol. 47, # 2, p. 177 - 181
[2] ChemSusChem, 2016, vol. 9, # 1, p. 67 - 74
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 20, p. 8540 - 8562
[4] Analytical Chemistry, 2014, vol. 86, # 17, p. 8693 - 8699
[5] Arzneimittel-Forschung/Drug Research, 1987, vol. 37, # 10, p. 1103 - 1107
[6] Journal of Medicinal Chemistry, 1997, vol. 40, # 13, p. 2047 - 2052
[7] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 10, p. 2519 - 2525
[8] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 2, p. 371 - 385
[9] Molecular Crystals and Liquid Crystals, 2007, vol. 474, # 1, p. 67 - 76
[10] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 4, p. 1378 - 1383
[11] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 4, p. 1822 - 1826
[12] Journal of Enzyme Inhibition and Medicinal Chemistry, 2014, vol. 29, # 2, p. 205 - 214
[13] Synthetic Communications, 2014, vol. 44, # 5, p. 600 - 609
[14] Journal of Chemistry, 2016, vol. 2016,
[15] Bioorganic and Medicinal Chemistry, 2018,
  • 4
  • [ 90-99-3 ]
  • [ 841-77-0 ]
Reference: [1] Archiv der Pharmazie, 1988, vol. 321, # 3, p. 171 - 174
[2] Yakugaku Zasshi, 1954, vol. 74, p. 1049[3] Chem.Abstr., 1955, p. 11666
  • 5
  • [ 7755-92-2 ]
  • [ 90-99-3 ]
  • [ 841-77-0 ]
Reference: [1] Patent: US5147876, 1992, A,
  • 6
  • [ 90-99-3 ]
  • [ 750512-44-8 ]
  • [ 298-57-7 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 5, p. 600 - 609
  • 7
  • [ 90-99-3 ]
  • [ 298-57-7 ]
Reference: [1] ChemSusChem, 2016, vol. 9, # 1, p. 67 - 74
  • 8
  • [ 108-01-0 ]
  • [ 90-99-3 ]
  • [ 58-73-1 ]
Reference: [1] Chemical Science, 2013, vol. 4, # 7, p. 2822 - 2827
[2] Patent: US2751388, 1950, ,
[3] Patent: DE927689, 1952, ,
[4] Chemical Science, 2017, vol. 8, # 6, p. 4363 - 4370
[5] Patent: DE927689, 1952, ,
[6] Patent: US2751388, 1950, ,
  • 9
  • [ 108-01-0 ]
  • [ 90-99-3 ]
  • [ 58-73-1 ]
  • [ 574-42-5 ]
Reference: [1] Chemical Science, 2013, vol. 4, # 7, p. 2822 - 2827
  • 10
  • [ 90-99-3 ]
  • [ 27329-60-8 ]
Reference: [1] Patent: JP2005/200358, 2005, A, . Location in patent: Page/Page column 35-36
  • 11
  • [ 90-99-3 ]
  • [ 122-52-1 ]
  • [ 27329-60-8 ]
Reference: [1] Patent: JP2005/298421, 2005, A, . Location in patent: Page/Page column 40
[2] Patent: JP2005/213183, 2005, A, . Location in patent: Page/Page column 40
[3] European Journal of Medicinal Chemistry, 1993, vol. 28, # 12, p. 943 - 948
  • 12
  • [ 60-29-7 ]
  • [ 762-04-9 ]
  • [ 90-99-3 ]
  • [ 27329-60-8 ]
Reference: [1] Uchenye Zapiski, Kazanskii Gosudarstvennyi Universitet, 1956, vol. 116, # 2, p. 71,108, 109[2] Chem.Abstr., 1957, p. 6581
  • 13
  • [ 108-01-0 ]
  • [ 90-99-3 ]
  • [ 147-24-0 ]
Reference: [1] Science, 2016, vol. 352, # 6281, p. 61 - 67
  • 14
  • [ 108-01-0 ]
  • [ 90-99-3 ]
  • [ 147-24-0 ]
  • [ 2498-25-1 ]
Reference: [1] Chemical Science, 2013, vol. 4, # 7, p. 2822 - 2827
  • 15
  • [ 90-99-3 ]
  • [ 147-24-0 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1952, vol. 71, p. 431
  • 16
  • [ 108-01-0 ]
  • [ 90-99-3 ]
  • [ 147-24-0 ]
  • [ 2498-25-1 ]
Reference: [1] Chemical Science, 2013, vol. 4, # 7, p. 2822 - 2827
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 90-99-3 ]

Aryls

Chemical Structure| 7510-28-3

[ 7510-28-3 ]

1-Benzyl-2-(chloromethyl)benzene

Similarity: 0.90

Chemical Structure| 23429-44-9

[ 23429-44-9 ]

(Chloro(p-tolyl)methylene)dibenzene

Similarity: 0.88

Chemical Structure| 86-52-2

[ 86-52-2 ]

1-(Chloromethyl)naphthalene

Similarity: 0.83

Chemical Structure| 102-46-5

[ 102-46-5 ]

4-(Chloromethyl)-1,2-dimethylbenzene

Similarity: 0.79

Chemical Structure| 1585-16-6

[ 1585-16-6 ]

alpha-2-Chloroisodurene

Similarity: 0.77

Chlorides

Chemical Structure| 7510-28-3

[ 7510-28-3 ]

1-Benzyl-2-(chloromethyl)benzene

Similarity: 0.90

Chemical Structure| 23429-44-9

[ 23429-44-9 ]

(Chloro(p-tolyl)methylene)dibenzene

Similarity: 0.88

Chemical Structure| 86-52-2

[ 86-52-2 ]

1-(Chloromethyl)naphthalene

Similarity: 0.83

Chemical Structure| 102-46-5

[ 102-46-5 ]

4-(Chloromethyl)-1,2-dimethylbenzene

Similarity: 0.79

Chemical Structure| 1585-16-6

[ 1585-16-6 ]

alpha-2-Chloroisodurene

Similarity: 0.77

Benzyl Chlorides

Chemical Structure| 7510-28-3

[ 7510-28-3 ]

1-Benzyl-2-(chloromethyl)benzene

Similarity: 0.90

Chemical Structure| 23429-44-9

[ 23429-44-9 ]

(Chloro(p-tolyl)methylene)dibenzene

Similarity: 0.88

Chemical Structure| 86-52-2

[ 86-52-2 ]

1-(Chloromethyl)naphthalene

Similarity: 0.83

Chemical Structure| 102-46-5

[ 102-46-5 ]

4-(Chloromethyl)-1,2-dimethylbenzene

Similarity: 0.79

Chemical Structure| 1585-16-6

[ 1585-16-6 ]

alpha-2-Chloroisodurene

Similarity: 0.77